Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockbuphoonon Jul 14, 2019 9:19am
115 Views
Post# 29917883

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:message for bashers/comedians

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:message for bashers/comediansI will be surprized if they drag one deal across the line. And the only deal may be to sell resins business which is a lumpy revenue business. Not sure if Ryplazim term sheets in January is not just another debacle like 36 months of pregnant deals on 4050. Complete lies. They were not even trying to do a placebo trial despite putting it on their slides in 2016 as “next milestones”. Spending $350M on salaries in 3 years with nothing but a 10 person Alstrom phase 2 and no revenue is simply too stupid for words. Pritchard should have been thrown out but he’s making fantastic money equal to a $1-3B market cap peer group. Pierre Layton, Simon Best and Ken Galbraith should have fired him immediately but I guess Clulow and Thomson saw a yes man who would screw existing shareholders and kiss Thomvests a$$.

pandorom999 wrote: if news are as expected you will see 80 in 18-24 months...


Bullboard Posts